Latest News & Features
Americas
Cindy Ahn, a former counsel at Schiff Hardin, has joined private equity firm Longford Capital to help handle demand for litigation finance among life sciences and biotech firms. 6 November 2017
Americas
Pharmaceutical companies have entered into fewer potential ‘pay-for-delay’ patent settlements for the second year in a row, following the US Supreme Court’s decision in FTC v Actavis. 6 November 2017
Americas
A US House of Representatives committee has called a hearing on the issue of IP rights being owned by entities that claim sovereign immunity. 6 November 2017
Americas
Biopharmaceutical company Sarepta Therapeutics is exploring the potential of CRISPR/Cas9 gene editing technology to treat Duchenne muscular dystrophy (DMD). 3 November 2017
Americas
Canada-based Valeant has agreed to pay $13 million to biotechnology company PDL BioPharma to settle a dispute over royalties. 2 November 2017
Americas
Watson Laboratories has secured a win at the US Court of Appeals for the Federal Circuit, after the court said Watson did prove that Bayer’s patent claims were obvious. 2 November 2017
Big Pharma
The English Court of Appeal has ruled that patent claims protecting blockbuster drug Cialis (tadalafil) are invalid as obvious, handing victory to Actavis, Teva and Mylan. 1 November 2017
Big Pharma
Swiss pharmaceutical company Novartis has bolstered its oncology portfolio with the acquisition of Advanced Accelerator Applications. 1 November 2017
Americas
The Patent Trial and Appeal Board has agreed to rehear an inter partes review (IPR) filed by Hospira, a company now owned by Pfizer. 31 October 2017
Americas
Bayer Healthcare and Mylan have settled their differences over a generic version of Bayer’s liver cancer drug Nexavar (sorafenib tosylate). 30 October 2017